Ultracet Contraindications

ULTRACET (tramadol hydrochloride and paracetamol) tablets is contraindicated in: Patients who are hypersensitive to the active substance tramadol and paracetamol or other opioid analgesics or to any ingredient in the formulation. For a complete listing, see Description.
Patients with known or suspected mechanical gastrointestinal obstruction (e.g., bowel obstruction or strictures) or any diseases/conditions that affect bowel transit (e.g., ileus of any type).
Patients with suspected surgical abdomen (e.g., acute appendicitis or pancreatitis).
Patients with severe hepatic or renal impairment (creatinine clearance of less than 30 mL/min and/or Child-Pugh Class C).
Patients with mild pain that can be managed with other pain medications.
Patients with acute or severe bronchial asthma, chronic obstructive airway, or status asthmaticus.
Patients with acute respiratory depression, elevated carbon dioxide levels in the blood, and cor pulmonale.
Patients with acute alcoholism, delirium tremens, and convulsive disorders.
Patients with severe CNS depression, increased cerebrospinal or intracranial pressure, and head injury.
Patients taking monoamine oxidase inhibitors (MAOIs) (or within 14 days following discontinuation of such therapy).
Women who are pregnant, nursing or during labour and delivery.
Any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, centrally acting analgesics, opioids or psychotropic drugs. ULTRACET may worsen central nervous system and respiratory depression in these patients.
Post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy.
All children younger than 12 years of age.